OncoSil Medical Limited (OSL.AX)
AUD 0.0
(0.0%)
AUD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 1.56 Million AUD | 325.75% |
| 2023 | 367.67 Thousand AUD | 58.63% |
| 2022 | 231.78 Thousand AUD | 8.79% |
| 2021 | 213.07 Thousand AUD | -92.29% |
| 2020 | 2.76 Million AUD | -23.78% |
| 2019 | 3.62 Million AUD | -18.47% |
| 2018 | 4.44 Million AUD | 26.56% |
| 2017 | 3.51 Million AUD | -8.42% |
| 2016 | 3.83 Million AUD | 39.18% |
| 2015 | 2.75 Million AUD | 772.92% |
| 2014 | 315.85 Thousand AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | -100.0% |
| 2010 | 2.08 Million AUD | -9.37% |
| 2009 | 2.3 Million AUD | 11.58% |
| 2008 | 2.06 Million AUD | 17.37% |
| 2007 | 1.75 Million AUD | 16.31% |
| 2006 | 1.51 Million AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 320.89 Thousand AUD | -12.73% |
| 2024 Q2 | 87.95 Thousand AUD | 0.0% |
| 2024 Q4 | 232.93 Thousand AUD | 0.0% |
| 2023 FY | 367.67 Thousand AUD | 58.63% |
| 2023 Q4 | 151.35 Thousand AUD | 0.0% |
| 2023 Q2 | 216.32 Thousand AUD | 0.0% |
| 2022 FY | 231.78 Thousand AUD | 8.79% |
| 2022 Q2 | 111.67 Thousand AUD | 0.0% |
| 2022 Q4 | 120.11 Thousand AUD | 0.0% |
| 2021 Q4 | 120.49 Thousand AUD | 0.0% |
| 2021 Q2 | 92.57 Thousand AUD | 0.0% |
| 2021 FY | 213.07 Thousand AUD | -92.29% |
| 2020 Q4 | 1.59 Million AUD | 0.0% |
| 2020 FY | 2.76 Million AUD | -23.78% |
| 2020 Q2 | 1.16 Million AUD | 0.0% |
| 2019 FY | 3.62 Million AUD | -18.47% |
| 2019 Q4 | 1.81 Million AUD | 0.0% |
| 2019 Q2 | 1.81 Million AUD | 0.0% |
| 2018 Q4 | 2.64 Million AUD | 0.0% |
| 2018 FY | 4.44 Million AUD | 26.56% |
| 2018 Q2 | 1.8 Million AUD | 0.0% |
| 2017 Q2 | 900 Thousand AUD | 0.0% |
| 2017 FY | 3.51 Million AUD | -8.42% |
| 2017 Q4 | 2.61 Million AUD | 0.0% |
| 2016 FY | 3.83 Million AUD | 39.18% |
| 2016 Q2 | 2.5 Million AUD | 0.0% |
| 2016 Q4 | 1.33 Million AUD | 0.0% |
| 2015 FY | 2.75 Million AUD | 772.92% |
| 2015 Q4 | 1.5 Million AUD | 0.0% |
| 2015 Q2 | 1.25 Million AUD | 0.0% |
| 2014 Q4 | 315.85 Thousand AUD | 0.0% |
| 2014 FY | 315.85 Thousand AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q1 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q1 | 521.78 Thousand AUD | 0.0% |
| 2011 Q3 | - AUD | 0.0% |
| 2011 FY | - AUD | -100.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 Q2 | - AUD | -100.0% |
| 2010 Q3 | 521.78 Thousand AUD | 0.0% |
| 2010 Q2 | 521.78 Thousand AUD | -9.37% |
| 2010 FY | 2.08 Million AUD | -9.37% |
| 2010 Q4 | 521.78 Thousand AUD | 0.0% |
| 2010 Q1 | 575.72 Thousand AUD | 0.0% |
| 2009 FY | 2.3 Million AUD | 11.58% |
| 2009 Q4 | 575.72 Thousand AUD | 0.0% |
| 2009 Q1 | 508.51 Thousand AUD | 0.0% |
| 2009 Q2 | 575.72 Thousand AUD | 13.22% |
| 2009 Q3 | 575.72 Thousand AUD | 0.0% |
| 2008 Q2 | 508.51 Thousand AUD | 15.68% |
| 2008 Q1 | 439.59 Thousand AUD | 0.0% |
| 2008 FY | 2.06 Million AUD | 17.37% |
| 2008 Q4 | 508.51 Thousand AUD | 0.0% |
| 2008 Q3 | 508.51 Thousand AUD | 0.0% |
| 2007 Q4 | 439.59 Thousand AUD | 0.0% |
| 2007 Q2 | 439.59 Thousand AUD | 16.31% |
| 2007 Q1 | 377.95 Thousand AUD | 0.0% |
| 2007 FY | 1.75 Million AUD | 16.31% |
| 2007 Q3 | 439.59 Thousand AUD | 0.0% |
| 2006 FY | 1.51 Million AUD | 0.0% |
| 2006 Q4 | 377.95 Thousand AUD | 0.0% |
| 2006 Q2 | 377.95 Thousand AUD | 0.0% |
| 2006 Q1 | - AUD | 0.0% |
| 2006 Q3 | 377.95 Thousand AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q3 | - AUD | 0.0% |
| 2005 Q2 | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | 58.304% |
| Adherium Limited | 840.98 Thousand AUD | -86.138% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 97.529% |
| Atomo Diagnostics Limited | 4.08 Million AUD | 61.694% |
| Anteris Technologies Ltd | 4.11 Million AUD | 61.923% |
| Control Bionics Limited | 5.12 Million AUD | 69.467% |
| CardieX Limited | 10.9 Million AUD | 85.646% |
| Compumedics Limited | 49.71 Million AUD | 96.852% |
| Cochlear Limited | 2.25 Billion AUD | 99.931% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 90.043% |
| Cyclopharm Limited | 27.13 Million AUD | 94.232% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 86.047% |
| Nova Eye Medical Limited | 23.32 Million AUD | 93.289% |
| HeraMED Limited | 402.89 Thousand AUD | -288.532% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -154.299% |
| ImpediMed Limited | 10.31 Million AUD | 84.83% |
| InhaleRx Limited | 1.2 Million AUD | -30.01% |
| LBT Innovations Limited | 1.25 Million AUD | -24.632% |
| Micro-X Limited | 15.22 Million AUD | 89.716% |
| Neurotech International Limited | 1963.00 AUD | -79644.422% |
| PolyNovo Limited | 103.19 Million AUD | 98.483% |
| Respiri Limited | 456.91 Thousand AUD | -242.599% |
| SomnoMed Limited | 91.65 Million AUD | 98.292% |
| Universal Biosensors, Inc. | 6.63 Million AUD | 76.399% |
| Uscom Limited | 3.72 Million AUD | 57.997% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | 81.945% |